<DOC>
	<DOCNO>NCT03088410</DOCNO>
	<brief_summary>The purpose study assess early longitudinal metabolic effect include insulin sensitivity HIV-exposed uninfected ( HEU ) child compare HIV-unexposed uninfected ( HUU ) child ; well determine difference effect neonatal zidovudine ( AZT ) vs. nevirapine ( NVP ) prophylaxis early longitudinal change insulin sensitivity first 3 year life .</brief_summary>
	<brief_title>Study HIV-Infected Uninfected Pregnant Woman/Child Dyads Gabarone , Botawana</brief_title>
	<detailed_description>This study consist nest randomized component HIV-infected ( HIV+ ) -uninfected ( HIV- ) pregnant woman/child dyad Botswana take place Gaborone , Botswana Botswana-Harvard AIDS Institute Partnership 's ( BHPs ) clinical research facility . A total 300 HIV+ pregnant woman/fetus dyad cART 150 HIV- pregnant woman/fetus dyad evaluate insulin sensitivity follow child 's 3rd birthday . Amongst HEU infant , participant randomize birth 1:1 150 receive neonatal AZT prophylaxis 150 receive neonatal NVP prophylaxis . Targeted metabolomics use assess role intermediary metabolite insulin resistance directly assess mitochondrial function use Seahorse XF96e technology . At time study enrollment , woman must willing exclusively breastfeed infant 's first 6 month life . If utero neonatal HIV/ARV exposures find associated derangement intermediary metabolism HEU infant increase risk insulin resistance 3 year age , would impact screen prevention strategy diabetes vulnerable population argue research identify prenatal neonatal ARV regimens superior PMTCT efficacy minimal adverse metabolic consequence .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>HIVinfected uninfected pregnant woman 1636 week GA eligible study enrollment . Women must 18 year older able provide inform consent infant participate study Participants must Botswana citizen Women must evidence HIVinfected status , either documentation HIVpositive test documentation HIV treatment , undergo HIV test counsel rapid diagnostic test confirm HIV status time enrollment documentation HIVpositive status provide . HIVuninfected woman must willing undergo HIV pretest counseling , rapid HIV test posttest counseling , refer HIV Testing Counseling ( HTC ) pregnancy . Women must willing remain study area infant attend schedule study visit describe child 's 3rd birthday For HIVinfected woman , must TDF/3TC FTC/EFV TDF/3TC FTC/Dolutegravir time study enrollment willing initiate treatment continue throughout period breastfeeding , lifetime . All woman must willing breastfeed exclusively first six month life . All enrol infant must product singleton birth . If mother enrol study antenatally deliver twin triplet , mother place study count toward accrual goal . Preexisting maternal diabetes mellitus HIV+ pregnant woman &lt; 4 week cART prior delivery HIV RNA level &gt; 400 copies/mL delivery Infants congenital anomaly life threaten illness birth would likely preclude survival 12 month age . Infants test positive HIV infection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>